EUVIMEDEUVIMED entdecken
Übersichtsarbeit

CRISPR‐Cas9 delivery strategies and applications: Review and update

Ali Alizadeh Severi, Bahman Akbari iD

genesis · 2024-06 · 62 (3)

DOI: 10.1002/dvg.23598 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift genesis, online erschienen am 10.05.2024. Verfasst von Ali Alizadeh Severi und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Biotechnology, School of Medicine, Kermanshah University of Medical Science, Kermanshah, Iran. Hauptthemen laut MEDLINE: CRISPR-Cas Systems, Gene Editing. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 117 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nowadays, a significant part of the investigations carried out in the medical field belong to cancer treatment. Generally, conventional cancer treatments, including chemotherapy, radiotherapy, and surgery, which have been used for a long time, are not sufficient, especially in malignant cancers. Because genetic mutations cause cancers, researchers are trying to treat these diseases using genetic engineering tools. One of them is clustered regularly interspaced short palindromic repeats (CRISPR), a powerful tool in genetic engineering in the last decade. CRISPR, which forms the CRISPR‐Cas structure with its endonuclease protein, Cas, is known as a part of the immune system (adaptive immunity) in bacteria and archaea. Among the types of Cas proteins, Cas9 endonuclease has been used in many scientific studies due to its high accuracy and efficiency. This review reviews the CRISPR system, focusing on the history, classification, delivery methods, applications, new generations, and challenges of CRISPR‐Cas9 technology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CRISPR-Cas SystemsGene EditingHumansNeoplasmsAnimalsGenetic TherapyGene Transfer Techniques

Stichwörter der Autor:innen

CRISPR‐Cas9HDRNHEJdelivergene editingsgRNA

Autor:innen und Institutionen

  • Department of Medical Biotechnology, School of Medicine, Kermanshah University of Medical Science, Kermanshah, Iran.

ORCID-Profile: Bahman Akbari

Zitieren

APA

Severi, A. A., & Akbari, B. (2024). CRISPR‐Cas9 delivery strategies and applications: Review and update. genesis, 62(3). https://doi.org/10.1002/dvg.23598

Vancouver

Severi AA, Akbari B. CRISPR‐Cas9 delivery strategies and applications: Review and update. genesis. 2024;62(3). doi:10.1002/dvg.23598

BibTeX
@article{Severi2024,
  author = {Severi, Ali Alizadeh and Akbari, Bahman},
  title = {CRISPR‐Cas9 delivery strategies and applications: Review and update},
  journal = {genesis},
  year = {2024},
  volume = {62},
  number = {3},
  doi = {10.1002/dvg.23598}
}
Kostenlos starten →